Company Search:
Advanced Search
Sponsored Links
Biovica International AB Company Snapshot
Biovica International AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biovica International AB with three other miscellaneous service companies in Europe: Diamyd Medical Ab (2018 sales of 726,000.00 Swedish Kronor [US$79,954.38 ] ), Reneuron Group PLC of the United Kingdom (£43,000.00 [US$55,771.86 ] of which 100% was Cell-Based Therapies), and Provexis PLC which is also based in the United Kingdom (£235,804.00 [US$305,842.50 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biovica International AB
  Stock Performance Chart for Biovica International AB
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 9.60
(Figures in Swedish Kronor)
1 Week 1.1%   13 Weeks 7.6%  
4 Weeks 10.6%   52 Weeks -20.7%  
Biovica International AB Key Data:
  Ticker: BIOVIC B Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 2,723,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 168,704,371
  Fiscal Yr Ends: April Shares Outstanding: 17,573,372
  Share Type: Aktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.